In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Selected Start-Ups Founded in 1999 (10/99)

Executive Summary

{In Vivo} summarizes the technologies of several medical companies founded within the last year. Confluent Surgical Inc. is developing novel synthetic hydrogels for use as an internal wound dressing and as an embolic agent. FastTrack Systems Inc. aims to improve the time, cost, and quality of clinical trials through its medical informatics technology. Matrix Therapeutics Ltd. was founded to manage the early phase of drug development for products created at the University of Manchester. Principia Pharmaceutical Corp. was launched to develop recombinant albumin-based fusion proteins against cancer, viral diseases and growth deficiencies. Syntonix Pharmaceuticals is focused on the non-invasive delivery of biopharmaceuticals. Tosk Inc. was spun-out of Stanford University to develop animal models and screening systems for the identification of drug candidates based on their in-animal efficacy and safety.
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001292

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel